REGENOCELL THERAPEUTICS, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
REGENOCELL THERAPEUTICS, INC. reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $227.31 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2012-05-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2012-05-25
- REGENOCELL THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2011-12-31 was $28.23K.
- REGENOCELL THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2011-09-30 was -$40.02K, a 112.82% decline year-over-year.
- REGENOCELL THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2010-12-31 was -$337.18K.
- REGENOCELL THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2010-09-30 was $312.19K.
- REGENOCELL THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2011 was $227.31K, a 36.13% decline from fiscal 2010.
- REGENOCELL THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2010 was $355.89K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2011-12-31 | $28.23K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-25 | -$11.79K derived: sum of 2 quarters · filed 2012-05-25 | $227.31K 10-K · filed 2012-05-25 | |
| 2011-09-30 | -$40.02K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | $199.08K 10-Q · filed 2011-11-21 | ||
| 2011-06-30 | $239.10K 10-Q/A · filed 2011-09-01 | |||
| 2010-12-31 | -$337.18K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-25 | -$24.99K derived: sum of 2 quarters · filed 2012-05-25 | $355.89K 10-K · filed 2012-05-25 | |
| 2010-09-30 | $312.19K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | $693.07K 10-Q · filed 2011-11-21 | ||
| 2010-06-30 | $380.87K 10-Q/A · filed 2011-09-01 |